Elliott Michael James 4
4 · Immunovant, Inc. · Filed Mar 23, 2021
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Elliott Michael James
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-19+342,300→ 342,300 totalExercise: $17.00Exp: 2031-03-19→ Common Stock (342,300 underlying) - Award
Common Stock
2021-03-19+97,600→ 97,600 total
Footnotes (3)
- [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
- [F2]The RSUs vest over four years, with 25% of the RSUs vesting on March 19, 2022 and the remainder of the RSUs vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
- [F3]Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.